We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

128 hedge funds and large institutions have $1.07B invested in Dr. Reddy's Laboratories in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $1B → $1.07B (+$61M)

0.79% more ownership

Funds ownership: 75.46% → 76.25% (+0.79%)

9% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 46

4% less funds holding

Funds holding: 134 → 128 (-6)

12% less call options, than puts

Call options by funds: $548K | Put options by funds: $623K

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
128
Holders Change
-6
Holders Change %
-4.48%
% of All Funds
3.19%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
42
Reduced
46
Closed
19
Calls
$548K
Puts
$623K
Net Calls
-$75K
Net Calls Change
+$884K

Top Buyers

1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$36.3M
2
Renaissance Technologies
Renaissance Technologies
New York
+$7.09M
3
First Trust Advisors
First Trust Advisors
Illinois
+$6.86M
4
CBOA
Commonwealth Bank of Australia
Australia
+$6.86M
5
Deutsche Bank
Deutsche Bank
Germany
+$4.51M

Top Sellers

1
AQR Capital Management
AQR Capital Management
Connecticut
-$20M
2
AI
Axiom Investors
Connecticut
-$11.1M
3
CS
Credit Suisse
Switzerland
-$7M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$3.12M
5
BlackRock
BlackRock
New York
-$2.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Credit Suisse
Switzerland
$6.43M -$7M -860,390 -53%
PPA
27
Parametric Portfolio Associates
Washington
$5.42M -$2.19M -269,720 -30%
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
$5.26M -$1.43M -175,485 -22%
DZ Bank
29
DZ Bank
Germany
$5.1M +$550K +67,685 +13%
Legal & General Group
30
Legal & General Group
United Kingdom
$4.69M -$110K -13,500 -2%
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
$4.5M +$1.23M +151,650 +40%
Swiss National Bank
32
Swiss National Bank
Switzerland
$4.39M – – –
CFSG
33
Community Financial Services Group
Vermont
$4.17M +$86K +10,575 +2%
State of New Jersey Common Pension Fund D
34
State of New Jersey Common Pension Fund D
New Jersey
$4.16M – – –
Millennium Management
35
Millennium Management
New York
$4.13M +$2.35M +289,055 +144%
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$4.02M -$254K -31,195 -6%
UBS Group
37
UBS Group
Switzerland
$4.01M -$348K -42,810 -8%
GH
38
GAM Holding
Switzerland
$3.98M +$416K +51,115 +12%
Aviva
39
Aviva
United Kingdom
$3.13M -$296K -36,395 -9%
SCM
40
Segantii Capital Management
Hong Kong
$3.09M +$2M +245,955 +197%
Bank of America
41
Bank of America
North Carolina
$3M -$406K -49,980 -12%
PHAM
42
Portland Hill Asset Management
United Kingdom
$2.65M -$91.5K -11,250 -3%
T. Rowe Price Associates
43
T. Rowe Price Associates
Maryland
$2.51M – – –
Goldman Sachs
44
Goldman Sachs
New York
$2.46M +$974K +119,835 +70%
Mitsubishi UFJ Trust & Banking
45
Mitsubishi UFJ Trust & Banking
Japan
$2.19M +$1.46M +179,650 +224%
Envestnet Asset Management
46
Envestnet Asset Management
Illinois
$2.14M -$191K -23,525 -8%
UCFA
47
United Capital Financial Advisors
Texas
$2.14M -$99.6K -12,250 -5%
Geode Capital Management
48
Geode Capital Management
Massachusetts
$2.03M -$49.7K -6,115 -2%
Nomura Holdings
49
Nomura Holdings
Japan
$1.7M – – –
Allianz Asset Management
50
Allianz Asset Management
Germany
$1.6M +$57.4K +7,055 +4%
1
2
3 4 5

RDY Hedge Fund Activity: Q2 2017 in Review

128 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2017, worth a combined $1.07B — up 6.1% from $1B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of RDY and 13 opened new positions — a net loss of 6 holders — while 46 trimmed existing stakes and 42 added.

The largest buyer was Royal Bank of Canada, adding an estimated $36.3M. The largest seller was AQR Capital Management, cutting an estimated $20M.

  • 128 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2017, down from 134 in Q1 2017.
  • Funds reported $1.07B of Dr. Reddy's Laboratories stock for Q2 2017, up 6.1% quarter-over-quarter.
  • 13 funds opened new Dr. Reddy's Laboratories positions in Q2 2017 and 19 closed out, a net change of -6 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q2 2017 was Royal Bank of Canada, an estimated $36.3M added.
  • The largest Dr. Reddy's Laboratories seller in Q2 2017 was AQR Capital Management, an estimated $20M sold.

Based on aggregated 13F filings for Q2 2017.